戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 isruption of delivery of insecticide-treated bednets.
2 eractions between vaccination and the use of bednets.
3 ic interactions between vaccines and treated bednets.
4 mine the interaction between vaccination and bednets.
5 ally of immunisation and insecticide-treated bednets.
6  iron fortification, and insecticide-treated bednets.
7 istance, and coverage of insecticide-treated bednets.
8 e evidence for these evolving so as to avoid bednets.
9 onia, and malaria (23%), insecticide-treated bednets (20%), vaccines (17%), reductions in wasting (11
10 e to the introduction of insecticide-treated bednets (25%); improvements in nutritional status (19%);
11 h family planning (27%), increased access to bednets (26%), household sociodemographics (17%), and im
12 eved significantly higher killing rates than bednets alone.
13    The BBnet's potential to augment existing bednets and enhance their performance is considered.
14 tion; approaches such as insecticide-treated bednets and epidemic preparedness may be needed to preve
15  both in women who owned insecticide-treated bednets and in women who did not.
16  increased deployment of insecticide-treated bednets and increased availability of highly effective a
17 control measures such as insecticide-treated bednets and indoor residual spraying are insufficient or
18 at target indoor-resting mosquitoes, such as bednets and insecticides, are currently the cornerstone
19 ent will be used in conjunction with treated bednets and other forms of malaria control.
20                            All children used bednets and received a single dose of sulfadoxine-pyrime
21 he pyrethroid deltamethrin (commonly used in bednets) and PM (widespread use for indoor spraying), in
22  Participants were given insecticide-treated bednets, and caregivers were encouraged to bring their c
23  resistance changes the efficacy of standard bednets, and those containing the synergist piperonyl bu
24 dditionally, insecticide-based tools such as bednets are compromised by insecticide-resistance allele
25              Long lasting pyrethroid treated bednets are the most important tool for preventing malar
26 ndoor-residual spraying, insecticide-treated bednets) are therefore inappropriate.
27 re randomized to receive insecticide-treated bednets at the start of phase 1 (111 villages) or phase
28                                      Barrier bednets (BBnets), regular bednets with a vertical insect
29 ind that the combination of BSV with treated bednets can lead to increased morbidity with no added va
30 We then investigated optimal vaccination and bednet control programs under two endemic settings with
31                             Switching to PBO bednets could avert up to 0.5 clinical cases per person
32        The personal protection provided by a bednet decreased over the study period and was lowest in
33            In addition, the efficacy of most bednets decreased significantly in 2021.
34 ng tablet administration, malaria treatment, bednet distribution, family planning, growth monitoring,
35 the course of 4 years surrounding nationwide bednet distribution.
36 ore individuals are indoors and protected by bednets, followed by a return to preintervention biting
37 1.04-1.16; p=0.001), and baby sleeping under bednet for 8-56 days (4548 [79%] of 5756 vs 4291 [73%] o
38 ard vaccinations ($12.96-25.93 per DALY) and bednets for malaria prevention ($6.48-22.04 per DALY).
39 dal net barriers positioned above a standard bednet in a spatial region of high mosquito activity but
40 tervention coverages for insecticide-treated bednets, indoor residual spraying, and effective treatme
41          The combination of TBV with treated bednets is synergistic, lowering both morbidity and elim
42                          Insecticide-treated bednets (ITNs) are effective in preventing malaria where
43       From 2004 to 2019, insecticide-treated bednets (ITNs) have been the most effective tool for red
44 thrin or deltamethrin in insecticide treated bednets (ITNs) to control malaria transmitted by pyrethr
45 ial to improve existing Insecticidal Treated Bednets (ITNs), by reducing the quantity of insecticide
46 the mass distribution of insecticide treated bednets (ITNs).
47 ogress has stalled(2), and with insecticidal bednets losing efficacy against pyrethroid-resistant Ano
48                                        Among bednets, only PBO-based nets (PermaNet 3.0 Top and Olyse
49  to mosquito positions being occluded by the bednet or other objects.
50 cide-treated nets at universal coverage (one bednet per two people).
51  a standard long-lasting deltamethrin-coated bednet (PermaNet 2.0).
52  with panel A (at the end of the rectangular bednet) presenting the highest mortality (54%).
53                                          New bednets provide substantial personal protection until hi
54  cast a cloud over control measures, such as bednet provision and insecticide spraying, by implying t
55                          Insecticide-treated bednets reduce malaria transmission and child morbidity
56 77% lower than in a neighboring area without bednets (risk ratio, 0.23; 95% confidence interval [CI],
57 de concentration was 0.5 ug/sample, with the bednet roof containing the highest average concentration
58 ticidal panel to target mosquitoes above the bednet roof, where they are most active, have the potent
59 malarial prophylaxis and insecticide-treated bednets should decrease stillbirths.
60 r health products (e.g., insecticide-treated bednets, soap, and water disinfectant) were marketed in
61  way for deploying many more insecticides on bednets than is currently possible.
62 on throughout much of Africa is dependent on bednets that are impregnated with pyrethroid insecticide
63 s in clinical malaria incidence with barrier bednets that matched those of 'next-generation' nets rec
64 re is strong synergy between PEV and treated bednets that may facilitate elimination, although transi
65                                      Barrier bednets that overcome insecticide resistance are feasibl
66 tion and distribution of insecticide-treated bednets timed to coincide with the 2015 malaria transmis
67  In Africa, where malaria burden is highest, bednets treated with pyrethroid insecticide were highly
68                                   Pyrethroid bednets treated with the synergist piperonyl butoxide (P
69                                     Reported bednet usage was nearly universal.
70 ri equivalence criteria in a setting of high bednet use (90.5%).
71                 Increases were also noted in bednet use during pregnancy (5398 [69%] of 7859 vs 5135
72                    There is no evidence that bednet use from birth increases all-cause mortality in o
73  8 unadjusted paired estimates; estimates of bednet use in 2009 met a priori equivalence criteria in
74                                 Adherence to bednet use in children younger than 5 years increased fr
75   Previous investigators have suggested that bednet use might paradoxically increase mortality in old
76 inations, estimates for behaviors other than bednet use remained substantially different.
77  it added to that of a single dose of SP and bednet use was modest.
78 t differ during 2002 (after up to 6 years of bednet use) between children from former intervention an
79 age, gender, wealth, modern housing, treated bednet use, agricultural land ownership, province, and r
80                Studied health behaviors were bednet use, obtaining care for fever, obtaining care for
81                        After 3 to 4 years of bednet use, the mean number of Anopheles mosquitoes per
82 ns per 100 people, even after accounting for bednet use, wealth, and housing structure.
83 , and 442 (88%) reported insecticide-treated bednet use.
84 ity following exposure to pyrethroid-treated bednets was low (< 30% mortality in cone bioassays).
85                Treated barriers on untreated bednets were equally effective, without significant loss
86 cluding RTS,S vaccination and pyrethroid-PBO bednets were in place, at least 60% more clinical cases
87 ublic health benefits of insecticide-treated bednets were sustained for up to 6 years.
88  IS strains around a human-baited, untreated bednet, were analysed using features such as velocity, a
89  an area with low use of insecticide-treated bednets, were randomly assigned to receive full screenin
90 icantly more effective than the reference P3 bednet while performance of untreated nets could be rais
91            Barrier bednets (BBnets), regular bednets with a vertical insecticidal panel to target mos
92 stant A. gambiae in Burkina Faso, pyrethroid bednets with organophosphate barriers achieved significa